Saturday, October 31, 2026

You Can See Everything

Saturday afternoon, Sharon and I went to see You Can See Everything at the CinemaWest Country Club. This is part of our annual journey to see all of the films that might be nominated for any Oscar. The movie has come out of nowhere over the last two months and jumped up a number of Best Picture Oscar lists.

You Can See Everything is a documentary film directed by Nathan Fielder and Lance Oppenheim. The film premiered as a secret screening at the 53rd Telluride Film Festival on September 6, 2026 and was theatrically released by A24 on October 16.

You Can See Everything follows disgraced Theranos founder Elizabeth Holmes and her partner Billy Evans as they grant a film crew unfettered access to their home in the weeks leading up to her prison sentence. Intended by Holmes to reshape her public image, the access instead turns into a complex, multi-year exploration of perception, truth, and mutual manipulation between the couple and the filmmaker.

Under Academy of Motion Picture Arts and Sciences (AMPAS) rules, documentary feature films are fully eligible to compete for Best Picture alongside narrative fiction films, provided they satisfy the standard distribution and theatrical requirements. While documentary films are eligible for Best Picture, a documentary has never received a Best Picture nomination in the history of the Oscars. Prediction markets currently place the odds of You Can See Everything securing a Best Picture nomination at ~82%.

The film is very unique. I recommend it.

About halfway through the film, Felder asks Elizabeth Holmes about the Theranos automated microfluidic blood analyzer. The answer that she gave surprised me. It wasn't consistent with what I had remembered about the collapse of the company. I have started to go back and read about what happened. I wish Felder had asked some follow-up questons about the purchase of off-the-shelf laboratory analyzer machines from standard manufacturer vendors and the diluting samples.

No comments:

Post a Comment